Journals / Dicle Tıp Dergisi / 2015 / Cilt: 42 - Sayı: 3

Anger, anxiety and depression in females with diffuse alopecia

Diffüz alopesili kadınlarda öfke, anksiyete ve depresyon

Pages
335–341
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that patients with alopecia revealed significantly more depression (p<0,001) and anxiety (p<0,001) scores than control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Present study aims to compare control group patients and patients with diffuse alopecia in order to un- derstand the nature of the relationship between symp- toms and level of anger and to see whether patient group has higher number of symptoms than control group.
📊
Key Findings & Data:Methods: 43 female patients who were diagnosed dif- fuse alopecia in dermatology clinic and 52 age-and- gender-matched control participants were included in the study. 20% of patients (n=19) with androgenetic alope- cia, 10.5% of patients (n=10) with diffuse alopecia areata and 14.7% of patients (n=14) with telogen effluvium par- ticipated in study.
💡
Conclusion & Impact:Results: It was found that patients with alopecia revealed significantly more depression (p<0,001) and anxiety (p<0,001) scores than control group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Present study aims to compare control group patients and patients with diffuse alopecia in order to un- derstand the nature of the relationship between symp- toms and level of anger and to see whether patient group has higher number of symptoms than control group. Methods: 43 female patients who were diagnosed dif- fuse alopecia in dermatology clinic and 52 age-and- gender-matched control participants were included in the study. 20% of patients (n=19) with androgenetic alope- cia, 10.5% of patients (n=10) with diffuse alopecia areata and 14.7% of patients (n=14) with telogen effluvium par- ticipated in study. Hospital Anxiety and Depression Scale (HADS) and The Trait Anger and Anger Expression Scale (TAAES) were filled by the participants. Also patients were followed up by a standard hospital form recording alopecia. Results: It was found that patients with alopecia revealed significantly more depression (p<0,001) and anxiety (p<0,001) scores than control group. Also trait anger (&#946; = 0,216, Wald Z = 3,697, Exp(B)= 1,241, p<0,05) and anxi- ety (&#946; = -0.466, Wald Z = 5,008, Exp(B)= 0.628, p<0,05) scores significantly predicted alopecia group. Additionally total time period for alopecia significantly and positively correlated with depression (r= 0,402, p<0.01) and anxiety (r=0,393, p<0,01) scores. Comparing patient groups with each other, trait anger and expressed anger were signifi- cantly different across groups. Conclusion: Patient group reported more anxiety and depressive symptoms than control group. In treatment of patients with alopecia, bidirectional relationship between alopecia and psychological symptoms should be in con- sideration. Collaboration with psychiatry is suggested in order to improve treatment efficacy and patients’ life sat- isfaction. In addition anger management seems essential in treatment of patients with diffuse alopecia

Özet

Amaç: Bu çalışmada diffüz alopesili hastalarda psikiyat- rik belirti sıklığının sağlıklı kontrollere göre daha fazla olup olmadığının belirlenmesi ve bunların öfke düzeyle- riyle ilişkisinin araştırılması amaçlanmıştır. Yöntemler: Bu çalışmaya dermatoloji polikliniğinde diffüz alopesi tanısı konulan 43 kadın hasta ile cinsiyet ve yaş açısından uyumlu sağlıklı 52 gönüllü dâhil edildi. Derma- tolojik tanı olarak diffüz alopesi alt tiplerinden androgene- tik alopesi tanısı alan 19 (%20,0), diffüz alopesia areata tanısı alan 10 (%10,5), telogen effluvium tanısı alan 14 (%14,7) kişi çalışmaya dâhil edildi. Hastalara ve kontrol grubuna Hastane Anksiyete ve Depresyon Ölçeği (HAD) ve Sürekli Öfke ve Öfke Tarz Ölçeği (SÖÖTÖ) uygulandı. Standart hazırlanan “Saç Dökülmesi Hasta Takip Formu”- na hastaların kayıtları yapıldı. Bulgular: Alopesili hasta grubunda sağlıklı kontrollere göre anksiyete (p<0.001) ve depresyon (p<0.001) pu- anları anlamlı olarak yüksek bulunmuştur. Ayrıca sürekli öfke (β = 0,216, Wald Z = 3,697, Exp(B)= 1,241, p<0,05) ve anksiyete (β = -0.466, Wald Z = 5,008, Exp(B)= 0.628, p<0,05) puanlarının tanı grubunu anlamlı derecede ön- gördüğü ve ayırt edici olduğu belirlendi. Saç dökülme sü- resinin, anlamlı ölçüde depresyon (r= 0,402, p<0.01) ve anksiyete (r=0,393, p<0.01) puanları ile pozitif korelas- yon gösterdiği bulundu. Dermatolojik tanılar birbirleriyle karşılaştırıldığında, sürekli öfke ve öfke dışa alt ölçekleri arasında anlamlı derecede farklılıklar saptandı. Sonuç: Alopesili hastalarda sağlıklı kontrollere göre ank- siyete ve depresif belirtilerin daha fazla olduğu tespit edil- miştir. Bu hastalara bu tür psikiyatrik rahatsızlıklar sıklıkla eşlik ettiği için psikiyatri kliniği ile işbirliği yapılması; hem tedavinin başarısını, hem de hastanın yaşam kalitesini olumlu yönde etkileyecektir. Ayrıca bu hastalarda öfke ve öfke ifade tarzı üzerinde de dikkatle durulmalıdır. Bu iliş- kinin farkında olmak diffüz alopesi hastalarının tedavisine katkı sağlayacaktır.

🔖

Cite This Article

ALDEMİR, S., ERPOLAT, S., TAN, S., DALBUDAK, E., TOPCU, M. (2015). Anger, anxiety and depression in females with diffuse alopecia. Dicle Tıp Dergisi, Cilt: 42 - Sayı: 3, 335–341. https://ajindex.com/articles/348853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Biondo S, Goble D, Sinclair R. Women who present with female pattern hair loss tend to underestimate the severity of their hair loss. Br J Dermatol 2004;150:750-752
  2. Wolff H. Diseases of hair. Braun-Falco’s Dermatology. Ed. Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, Braun-Falco O. 3rd ed. Italy, Springer, 2009;1029-1059
  3. Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Con- cepts of patients with alopecia areata about their disease. BMC Dermatol 2005;5:1
  4. Cash TF, Price VH, Savin RC. Psychological effects of an- drogenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993;29:568-575
  5. Werner B, Mulinari-Brenner F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alo- pecia areata--part II. An Bras Dermatol 2012;87:884-890
  6. Chartier MB, Hoss DM, Kels JMG. Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol 2002;47:809-818
  7. Harrison S, Sinclair R. Telogen Effluvium. Clin Exp Derma- tol 2002;27:389-395
  8. Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Gonzàlez- Amaro R. Severe and unresponsive HIV-associ- ated alopecia areata successfully treated with thalidomide. Acta Derm Venereol 2005;85:277–278
  9. Trueb RM. Diffuse hair loss in women. Ther Umsch 2002;59:217–222
  10. Price VH. Androgenetic alopecia in women. J Invest Der- matol 2003;8:24-27
  11. Trueb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges 2010;8:284-297
  12. Harth W, Blume-Peytavi U. Psychotrichology: psycho- somatic aspects of hair diseases. J Dtsch Dermatol Ges 2013;11:125-135
  13. Schmidt S, Fischer TW, Chren MM, et al. Strategies of cop- ing and quality of life in women with alopecia. Br J Derma- tol 2001;144:1038-1043
  14. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alo- pecia areata: psychiatric comorbidity and adjustment ofil- ness. Int J Dermatol 2003;42:434-437
  15. Camacho FM, Hernandez MJG. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol 2002;16:476-480
  16. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: Stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Der- matol 2004;123:455–457
  17. Altınöz AE, Taşkıntuna N, Altınöz ST, Ceran S. A cohort study of the relationship between anger and chronic sponta- neous urticaria. Adv Ther 2014;31:1000-1007